Iontronic Tech Promises Hope in Slowing Malignant Brain Tumors by Lilu Anderson 20.06.2024 "Iontronic tech shows promise in slowing malignant brain tumor growth by continuously delivering low-dose drugs, bypassing the blood-brain barrier."
G1 Therapeutics Phase 3 Trial Update: Market Response by Mark Eisenberg 13.02.2024 Shares of G1 Therapeutics plunged 46% after disappointing results from their Phase 3 trilaciclib combination trial for triple-negative breast cancer. ...